A result that held last month stops holding, and nothing in the procedure changed. The reagent is the same compound from the same supplier at the same stated purity. The only thing that moved is the lot number.
This is the most common silent variable in work with research peptides, and it is not usually a sign that anything was made badly. It is a consequence of how much a certificate does not measure, combined with the fact that the one number everybody compares — purity — is close to the least informative for this purpose.
Quick answer
Why do two lots of the same peptide behave differently? Because purity is a ratio within the peptide-related material, and most of what differs between lots sits outside that ratio. Water content, counterion load and residual solvent all change how much actual peptide a milligram contains. Epimer content, disulfide pairing and solid form change how the material behaves without changing its mass. And physical behaviour varies independently of chemistry — in a published comparison, three batches of the same product were comparable when unstressed but showed slight differences in aggregation tendency. The defence is to measure concentration rather than trusting the label, and to run an overlap experiment when switching lots.
What actually varies
| Variable | Effect | On a typical certificate? |
|---|---|---|
| Water content | Direct. Water is mass that is not peptide, so it dilutes every calculation made from the label. | Sometimes, by Karl Fischer |
| Counterion load | Direct, and can be substantial on peptides with several basic residues. Also sets the pH a reconstituted solution lands at. | Salt form sometimes; quantity rarely |
| Net peptide content | The figure that resolves both of the above. | Often absent |
| Epimer content | None on mass. Changes conformation and behaviour. | Essentially never |
| Disulfide pairing | None on mass. Changes structure entirely. | Essentially never |
| Residual solvent | Mass, plus whatever the solvent does in your system. | Sometimes, if a panel was run |
| Solid form and surface area | Changes reconstitution time and behaviour. | No |
| Aggregation tendency | Changes how the solution behaves under stress. | No |
Only the first and the sixth routinely appear as numbers. The rows that change behaviour without changing mass — epimers and disulfide pairing — are covered in racemisation and D-amino acids and disulfide bonds and oxidation state.
Why purity is the wrong number to compare
Purity is a ratio within the peptide-related material only. Two lots can both report 99% and contain different amounts of peptide per milligram, because water, counterion and residual solvent all sit outside that ratio. The point is developed in what 99% purity actually means and net peptide content versus purity.
There is a second, less obvious reason. A purity figure is a property of the analytical method as much as of the material. The integration rejection threshold determines which small peaks become impurities and which become baseline, and the detection limit determines what could have been seen at all. Neither is usually stated. Two lots analysed on a slightly different gradient are not strictly comparable even when both numbers are honest — see what not detected actually means.
This is why comparing lots within one supplier is more informative than comparing headline figures between suppliers. Within a supplier the method is usually held constant, so a change in the number is more likely to mean a change in the material.
Physical behaviour varies independently
The clearest published illustration comes from a study comparing analytical methods on thermally stressed material. Three batches of the same product were analysed, and the finding was that they were comparable when unstressed but showed slight differences in aggregation tendency once stressed.
That is the shape of the problem in one sentence. Tested at rest, the batches matched. Pushed, they diverged. A certificate describes material at rest.
The same logic applies to solid-state behaviour. Residual moisture sets the glass transition temperature of the dried solid, so a wetter lot is less stable in storage even at identical purity — covered in residual solvents and water content. And reconstitution time reflects solid form and surface area, which is why it is worth recording per lot, as set out in reading the vial before you open it.
Bridging between lots
Bridging means establishing the relationship between an old lot and a new one before the new one carries any conclusions. It is an analytical comparison, and for most purposes it is short.
Before the old lot runs out
This is the part people get wrong, because the opportunity is gone once the old vial is empty. Keep enough of the current lot to run alongside the next one. Without overlap there is no comparison, only a before and an after separated by every other thing that changed.
The comparison itself
- Measure concentration on both, against the same reference. Not calculated from the label — measured. This single step captures water, counterion and net peptide content in one number, and it is the highest-value thing on this list. Methods are in measuring peptide concentration.
- Run both on the same chromatographic method, in the same session. Same column, same gradient, same day. Compare retention time and peak shape, not just area percentages. A shifted retention time or a new shoulder says more than a purity figure.
- Record reconstitution time and clarity for both, in the same diluent at the same concentration.
- Normalise by measured concentration, not by mass weighed. If the two lots differ in net peptide content, equal masses are not equal amounts, and every downstream comparison inherits that error.
- Keep the diluent, pH and container identical across the comparison. Otherwise you are testing your handling rather than the lots.
What to conclude
If measured concentrations agree and the chromatograms overlay, the lots are interchangeable for most purposes. If concentrations differ, adjust by the measured ratio rather than treating it as noise. If the chromatograms differ in shape — a new peak, a shoulder, a shifted retention — that is a question for the supplier before the lot is used for anything that matters.
What to record
The value of a lot record is entirely in the comparison across lots, so the fields have to be identical every time and filled in even when nothing looks interesting.
- Lot number, date received, date first opened
- Water content and salt form from the certificate
- Net peptide content if stated, and the method
- Purity figure, and the detection limit or reporting threshold if given
- Appearance on arrival, described rather than graded
- Reconstitution time, diluent, concentration and final pH
- Measured concentration against reference, and the ratio to the previous lot
- Any observed difference from the preceding lot
Record limits alongside results. Three lots each marked not detected are not comparable to one another unless each one states what would have been detected.
What is reasonable to ask a supplier
- A lot-specific certificate rather than a representative one. This is the baseline expectation and the subject of why batch-specific testing matters.
- Whether the analytical method changed between the lots you are comparing.
- Water content and salt form as numbers, for both lots.
- Whether the synthesis route or scale changed. A process change is the most likely explanation for a step change in behaviour.
- Retention of some of the previous lot, if they hold it, when you have a discrepancy to resolve.
How to weigh the answers is covered in evaluating supplier certificates and lots.
Key takeaways
- Most of what differs between lots sits outside the purity ratio: water, counterion, residual solvent, epimer content, disulfide pairing, solid form.
- Purity is a property of the analytical method as well as the material, so compare lots within a supplier rather than headline figures between suppliers.
- In a published comparison, three batches were comparable unstressed and differed in aggregation tendency once stressed. Certificates describe material at rest.
- Measuring concentration against a reference captures water, counterion and net peptide content in a single number.
- Keep enough of the current lot to overlap with the next one. Without overlap there is no comparison.
- Normalise by measured concentration, not by weighed mass.
- A change in chromatogram shape is more informative than a change in the purity percentage.
Frequently asked questions
Both lots say 99%. Why would they differ?
Because 99% describes the proportion of peptide-related material that is the target sequence. It says nothing about how much of the vial is peptide at all, and nothing about stereochemistry, folding or physical behaviour. Two lots can match on that number and differ on most of what determines how they perform.
How much of the old lot should I keep?
Enough for the comparison you intend to run, which for a concentration measurement and a chromatographic injection is usually very little. The cost of keeping it is near zero; the cost of not having it is an unresolvable discrepancy.
Is lot variability a sign of a poor supplier?
Some variability is inherent to chemical synthesis and is not a quality failure. What distinguishes good supply is lot-specific documentation, a stable analytical method, and a straight answer when a process change happened. A supplier who issues the same certificate for every lot has removed your ability to tell.
Should I re-validate everything with each new lot?
No, and that would be disproportionate for most work. The proportionate step is measuring concentration on the new lot against a reference and running one chromatographic comparison. That catches the large majority of practically relevant differences.
What if the new lot is a different salt form?
Then it is a materially different starting point: the counterion is part of the mass, and it changes the pH a reconstituted solution reaches. Treat a salt-form change as a reason to bridge carefully rather than as a detail. See TFA versus acetate salts and reconstitution calculations.
Sources
- van Maarschalkerweerd A, Wolbink GJ, Stapel SO, Jiskoot W, Hawe A. Comparison of analytical methods to detect instability of etanercept during thermal stress testing. Eur J Pharm Biopharm. 2011;78(2):213–21. DOI
- Hibino H, Miki Y, Nishiuchi Y. Evaluation of acid-labile S-protecting groups to prevent Cys racemization in Fmoc solid-phase peptide synthesis. J Pept Sci. 2014;20(1):30–5. DOI
- International Council for Harmonisation. ICH Q2(R2): Validation of Analytical Procedures. ICH guideline
Journal citations retrieved via PubMed.
This article describes analytical documentation and laboratory practice only. It contains no usage instructions, no dosing information and no protocols of any kind.
For laboratory and in-vitro research use only. Not for human or veterinary use.
For laboratory and in-vitro research use only. Not for human or veterinary use. See our research-use disclaimer.
